Why the study?
Does droperidol, ondansetron, or their combination prevent post-operative vomiting in children undergoing surgery for strabismus?
Does droperidol, ondansetron, or their combination prevent post-operative vomiting in children undergoing surgery for strabismus?
Droperidol and ondansetron are equally effective at reducing post-operative vomiting in children undergoing strabismus surgery, and their combination offers no additional benefit.
Answers are grounded in this paper and cite their sources.
Either agent alone suffices to prevent emesis after pediatric strabismus surgery; confirms no additive benefit from combination.
In this study the antiemetic effects of droperidol, ondansetron and their combination were evaluated in 160 ASA Grade I and II children undergoing surgery for strabismus, who were randomly assigned to one of four groups: Group D received droperidol 75 μg kg−1, group O ondansetron 0.1 mg kg−1, group D + O received both droperidol 75 μg kg−1 and ondansetron 0.1 mg kg−1, and group N NaCl as placebo. Emesis within the first 24 h occurred in 95.0% of the children with placebo medication, compared with 32.5% (D), 40.0% (O) and 45.0% (D + O) in the groups with antiemetic prophylaxis. The differences between group N and all other groups were significant (P<0.001). However, there were no statistically significant differences between the groups D, O and D + O. It is concluded that droperidol (75 μg kg−1) and ondansetron (0.1 mg kg−1) both significantly reduce PONV in children undergoing surgery for strabismus. Neither ondansetron, nor the combination D + O were superior to droperidol alone.
No takes yet. Share an insight, caveat, or question.
Klockgether‐Radke et al. (1997) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: